Australia markets close in 5 hours 39 minutes
  • ALL ORDS

    7,225.00
    -27.30 (-0.38%)
     
  • ASX 200

    6,968.70
    -26.50 (-0.38%)
     
  • AUD/USD

    0.7620
    -0.0004 (-0.05%)
     
  • OIL

    59.58
    +0.26 (+0.44%)
     
  • GOLD

    1,742.20
    -2.60 (-0.15%)
     
  • BTC-AUD

    78,582.71
    -227.22 (-0.29%)
     
  • CMC Crypto 200

    1,277.56
    +50.02 (+4.08%)
     
  • AUD/EUR

    0.6399
    -0.0002 (-0.02%)
     
  • AUD/NZD

    1.0832
    +0.0007 (+0.06%)
     
  • NZX 50

    12,536.47
    -37.88 (-0.30%)
     
  • NASDAQ

    13,845.05
    +86.55 (+0.63%)
     
  • FTSE

    6,915.75
    -26.47 (-0.38%)
     
  • Dow Jones

    33,800.60
    +297.00 (+0.89%)
     
  • DAX

    15,234.16
    +31.46 (+0.21%)
     
  • Hang Seng

    28,698.80
    -309.30 (-1.07%)
     
  • NIKKEI 225

    29,755.40
    -12.66 (-0.04%)
     

Creating and Protecting IP Value in Connection with VC Financings

TC Video

How do venture capital investors value formal Intellectual Property (IP) rights in connection with a decision to fund a technology or life sciences start-up? How do they conduct IP due diligence? How do investors and founders, post-funding, ensure their start-ups are pursuing an IP strategy that optimizes exit valuation for all? Perkins Coie partners Michael Glenn (Patent Prosecution) and Matt Oshinsky (Emerging Companies Venture Capital) will be joined alongside a seasoned venture capitalist to discuss these and other questions regarding safeguarding IP rights and maximizing the value of all technology development activities.